Search clinical trials for: ribociclib ET

Total 309 results

Novartis Pharmaceuticals

Recruiting

Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France (RosaLEE)

Breast Cancer

France
Menoufia University
Alexandria University

Completed

Ultrasound Guidance for Embryo Transfer

Infertility

Egypt
Universidad de Zaragoza
University of Valladolid

Completed

Pain Education and Therapeutic Exercise for Fibromyalgia

Fibromyalgia

Spain
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

ElderTree Via a Voice Activated Device for Managing Chronic Health Conditions (NHLBI)

Chronic Conditions, Multiple

United States
Centre Hospitalier Universitaire, Amiens

Recruiting

MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD (IRM-ET)

Functional Magnetic Resonance Imaging | ASD | Social Cognition | Eye Tracking | Joint Attention

France
Vyaire Medical
M.D. Anderson Cancer Center

Completed

SuperNO2VA Et Versus Oxygen Face Mask During Deep Sedation (iOXYGENATE)

Hypoxemia

United States
Faculty of Medicine, Sousse

Completed

Chronic Obstructive Pulmonary Disease (COPD)

COPD

Tunisia
Institute of Hematology & Blood Diseases Hospital...
EdiGene Inc.; The Affiliated Hospital Of Guizhou Medical University; Zunyi Medical...

Active, not recruiting

Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia

Transfusion Dependent Beta-Thalassaemia

China
Novartis Pharmaceuticals

Recruiting

A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

Breast Cancer

Jordan
Nader Sanai
Novartis; Barrow Neurological Institute; Ivy Brain Tumor Center

Active, not recruiting

Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

Glioblastoma Multiforme | Meningioma

United States
Assaf-Harofeh Medical Center

Unknown

A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Soft-Tissue Sarcoma | Liposarcomas, Dedifferentiated | Liposarcoma - Well Differentiated | Liposarcoma; Mixed Type

Israel
Children's Hospital of Philadelphia
Anesthesia Patient Safety Foundation

Completed

The Videolaryngoscopy in Small Infants (VISI)

Surgery | Anesthesia, Endotracheal

United States, Australia
Institut fuer Frauengesundheit
Novartis Pharmaceuticals; AGO Breast Study Group e.V.

Recruiting

Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients (CAPTOR-BC)

Breast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer

Germany
Fox Chase Cancer Center

Terminated

Impact of Ribociclib on Head and Neck Squamous Cell Cancer

Squamous Cell Carcinoma of the Head and Neck

United States
EdiGene (GuangZhou) Inc.
PLA 923 Hospital

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia.

Transfusion Dependent Beta-Thalassaemia

China
VA Office of Research and Development

Active, not recruiting

Cognitive Rehab and Exposure Treatment for Hoarding (CREST)

Hoarding Disorder

United States
Hollister Incorporated

Completed

Assessment of an Endotracheal Tube Securement Device

Respiratory Insufficiency

United States
Children's Hospital Medical Center, Cincinnati
Novartis

Terminated

A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy

High Grade Glioma | Diffuse Intrinsic Pontine Glioma | Bithalamic High Grade Glioma

United States
Royan Institute

Completed

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Embryo Transfer on Pregnancy Outcomes in Frozen Embryo Transfer Cycles.

Infertility

Iran, Islamic Republic of
University of Utah

Completed

Enhancing Resilience in Young Stroke Survivors With Res-ET

Stroke | Resilience

United States
Johns Hopkins University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Interventions Made to Preserve Cognitive Function (IMPCT)

ESRD

United States
University of Turin, Italy

Completed

Transabdominal US-guided (UGET) vs. Modified Transvaginal US-guided (mTVET) Embryo Transfer in Human IVF

Infertility

Italy
Novartis Pharmaceuticals

Temporarily not available

Managed Access Programs for LEE011, Ribociclib

Breast Cancer
Novartis Pharmaceuticals

Completed

Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011

Normal Hepatic Function | Impaired Hepatic Function

United States
Hadassah Medical Organization

Unknown

A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Soft Tissue Sarcoma | Liposarcoma

Israel
Laval University

Unknown

Laval University Rouge et or Post ACL Surgery Program Effectiveness

Anterior Cruciate Ligament Injuries | ACL

Canada
University Hospital, Angers

Completed

Study of ADHD Children's Sensitivity to Memory Error Production (TDAH-DRM)

ADHD

France
Faculty of Medicine, Sousse

Completed

Exercise Training and Inflammatory Mediators in COPD

COPD

Tunisia
University of Wisconsin, Madison

Completed

Evaluation of Supralaryngeal Airway Removal During Initial Resuscitation of the Trauma Patient

Replacement of Supralaryngeal Airway

United States
University of Wisconsin, Madison
Agency for Healthcare Research and Quality (AHRQ)

Completed

ElderTree Smart System for Older Adults

Chronic Pain

United States
Array BioPharma

Terminated

Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.

Locally Advanced Metastatic BRAF Mutant Melanoma

Australia, Canada, Netherlands, United States
University of Washington
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Subgroups of Fibromyalgia Syndrome (FMS): Symptoms, Beliefs, and Tailored Treatment

Fibromyalgia

United States
SOLTI Breast Cancer Research Group
Novartis; UNICANCER

Recruiting

Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer (RIBOLARIS)

Breast Cancer Stage II

Spain, France, Portugal
West German Study Group
Novartis; Genomic Health®, Inc.

Recruiting

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC (ADAPTcycle)

Breast Cancer Female

Germany
Novartis Pharmaceuticals

Completed

Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer

Breast Cancer

Brazil
Novartis Pharmaceuticals

Recruiting

A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia (ValerEE)

HR+HER2- Advanced Breast Cancer

Russian Federation
Universidad Complutense de Madrid
Osteology Foundation

Recruiting

Partial-thickness/Non-advanced vs. Full-thickness/MCAT Tunnelling for the Treatment of Multiple Gingival Recessions (Tun_RCT)

Gingival Recession

Italy
Vastra Gotaland Region

Recruiting

Effect of the LEVAmethod by Bertz et al © in Subjects With Overweight or Obesity in Primary Health Care. (LEVA-POP)

Overweight and Obesity

Sweden
Capital Medical University

Completed

Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke (REVISE-1)

Acute Stroke

China
Centre Hospitalier Universitaire Dijon

Unknown

Study of the Impact of Implicit Motor Training in a Rehabilitation Programme in Frail Elderly Subjects (MAAMI)

Rehabilitation Frail Elderly Subjects

France
University of Michigan Rogel Cancer Center

Recruiting

Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer

Breast Cancer

United States
Swiss Group for Clinical Cancer Research
The Belgian Society of Medical Oncology

Terminated

Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC

Breast Cancer

Switzerland, Belgium, Austria
Tongji Hospital

Withdrawn

Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia

COVID-19 | Endotracheal Intubation

China
University of Oslo

Not yet recruiting

Early Intervention Coping Kids (TIM) Follow up Study (FOPPT4)

Depression | Anxiety Disorders
EdiGene (GuangZhou) Inc.

Active, not recruiting

A Safety and Efficacy Study Evaluating ET-01 in Subjects With Transfusion Dependent β-Thalassaemia (ET-01)

Transfusion Dependent Beta-Thalassaemia

China
Istituti Clinici Scientifici Maugeri SpA
Universita di Verona

Recruiting

Study on Impact of Maximal Strength Training in Patients With COPD

Chronic Obstructive Pulmonary Disease

Italy
Centre Hospitalier Universitaire de Nice

Unknown

Prospective Follow-up of Patients With Chronic Inflammatory Rheumatism (PPCRNice)

Rheumatoid Arthritis | Spondyloarthritis | Inflammatory Disease

France
Istanbul University - Cerrahpasa (IUC)

Completed

Effectiveness of Neuromuscular Electrical Stimulation in Patients With Subacromial Impingement Syndrome

Subacromial Impingement Syndrome

Turkey
Novartis Pharmaceuticals
Translational Research in Oncology

Active, not recruiting

A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer (NATALEE)

Early Breast Cancer

United States, Belgium, Canada, Italy, United Kingdom, Hungary, Taiwan, Australia, Germany, Spain, Austria, Russian Federation, Korea, Republic of, China, France, Brazil, Ireland, Argentina, Romania, Poland
The First Affiliated Hospital with Nanjing Medical...
Zhejiang Cancer Hospital

Recruiting

Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer

Advanced Breast Cancer

China

Search clinical trials for: ribociclib ET

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations